Anurag K. Singh, MD, is a board-certified hematologist-oncologist specializing in hematologic malignancies, cellular therapeutics, and blood and marrow transplantation. He serves as an Associate Professor of Medicine in the Division of Hematologic Malignancies and Cellular Therapeutics at the University of Kansas Medical Center and The University of Kansas Cancer Center, where he is also Deputy Director of the Blood and Marrow Transplant Program. Dr. Singh’s clinical practice centers on allogeneic and autologous stem cell transplantation, CAR T-cell therapy and other cellular immunotherapies, and comprehensive care for complex hematologic cancers across the treatment continuum. His research interests include optimizing cellular therapy and transplant platforms, improving prevention and risk prediction for transplant-related immune complications, and understanding hereditary and germline predisposition to hematologic malignancy. In addition to his program leadership, Dr. Singh has been recognized for advancing access to FDA-approved cellular therapies at KU Cancer Center and for consistently earning top patient experience ratings for clear communication and compassionate care. He received his MBBS from Maulana Azad Medical College, University of Delhi, and completed residency training in Internal Medicine followed by fellowship training in Hematology and Oncology at SUNY Upstate Medical University.
Associate Professor
Medical School
2000 – 2006
Residency
2008 – 2010
Fellowship
2010 – 2013